- Home
- PMAX vs KTTA Comparison
PMAX vs KTTA Comparison
Compare PMAX & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMAX
- KTTA
- Stock Information
- Founded
- PMAX 2019
- KTTA 2020
- Country
- PMAX Hong Kong
- KTTA United States
- Employees
- PMAX N/A
- KTTA N/A
- Industry
- PMAX
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- PMAX
- KTTA Health Care
- Exchange
- PMAX Nasdaq
- KTTA Nasdaq
- Market Cap
- PMAX 6.0M
- KTTA 5.5M
- IPO Year
- PMAX 2024
- KTTA 2021
- Fundamental
- Price
- PMAX $2.87
- KTTA $0.81
- Analyst Decision
- PMAX
- KTTA
- Analyst Count
- PMAX 0
- KTTA 0
- Target Price
- PMAX N/A
- KTTA N/A
- AVG Volume (30 Days)
- PMAX 90.1K
- KTTA 93.8K
- Earning Date
- PMAX 09-23-2025
- KTTA 11-12-2025
- Dividend Yield
- PMAX N/A
- KTTA N/A
- EPS Growth
- PMAX N/A
- KTTA N/A
- EPS
- PMAX N/A
- KTTA N/A
- Revenue
- PMAX $4,799,100.00
- KTTA N/A
- Revenue This Year
- PMAX N/A
- KTTA N/A
- Revenue Next Year
- PMAX N/A
- KTTA N/A
- P/E Ratio
- PMAX N/A
- KTTA N/A
- Revenue Growth
- PMAX N/A
- KTTA N/A
- 52 Week Low
- PMAX $1.87
- KTTA $0.65
- 52 Week High
- PMAX $31.92
- KTTA $5.45
- Technical
- Relative Strength Index (RSI)
- PMAX 91.41
- KTTA 61.44
- Support Level
- PMAX $0.26
- KTTA $0.70
- Resistance Level
- PMAX $0.29
- KTTA $0.84
- Average True Range (ATR)
- PMAX 0.15
- KTTA 0.03
- MACD
- PMAX 0.26
- KTTA 0.01
- Stochastic Oscillator
- PMAX 84.69
- KTTA 81.57
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).